<sup>18</sup>F-AlF-NOTA-Octreotide Outperforms<sup>68</sup>Ga-DOTATATE/NOC PET in Neuroendocrine Tumor Patients: Results from a Prospective, Multicenter StudyElin Pauwels, Christophe M. Deroose, Frederik Cleeren et al.|Journal of Nuclear Medicine|2022Cited by 74
Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only studyHeli Nevanlinna, Sten Cornelissen, Fergus J. Couch et al.|Breast Cancer Research|2017Cited by 60
Transoral robotic surgery (<scp>TORS</scp>) using the da Vinci Xi: prospective analysis of feasibility, safety, and outcomesJeroen Meulemans, Vincent Vander Poorten, Margaux Vanermen et al.|Head & Neck|2021Cited by 21
Palliative endovascular treatment of cancer-related iliocaval obstructive disease: technical and clinical outcomesGeert Maleux, Raymond Oyen, Bart Vertenten et al.|Acta Radiologica|2015Cited by 20
Influence of pretreatment with everolimus or sunitinib on the subacute hematotoxicity of <sup>177</sup>Lu-DOTATATE PRRTEva Medaer, Christophe M. Deroose, Chris Verslype et al.|Acta Oncologica|2020Cited by 10